About this episode
In this episode, Adityo Prakash, founder and CEO of Verseon, shares how his company is transforming drug discovery through deep quantum modeling and advanced computational science. He discusses the challenges of traditional drug development, the limitations of current AI approaches, and how Verseon’s technology is redefining how we tackle complex diseases like diabetes and cancer. Adityo also reflects on the company’s mission-driven culture, its focus on addressing root causes rather than symptoms, and the importance of building a scientific community to accelerate truly transformative medicine.Chapters:00:00 Introduction to Verseon and Adityo Prakash03:07 The Journey of Drug Discovery and Innovation06:03 Challenges in Current Drug Development Models08:57 The Role of AI in Drug Discovery11:58 Deep Quantum Modeling: A New Frontier15:11 Transforming Drug Development Processes18:07 Real-World Applications and Success Stories27:13 Innovations in Diabetes Treatment30:03 Advancements in Cancer Therapies32:09 The Vision Behind the Company35:02 Navigating Challenges in Drug Development35:58 The Role of Quantum Computing in Drug Discovery38:49 Choosing Disease Targets for Drug Development42:59 Leadership Evolution and Company Culture45:46 Attracting Investors and Building CommunityGuest Information:Guest's Name: Adityo PrakashGuest's Linkedin: https://www.linkedin.com/in/adityo-prakash-3a5b928/ Company / Affiliation: Verseon https://www.verseon.com/Guest's Bio: Adityo Prakash is a scientist-entrepreneur and the Founder & CEO of Verseon, where he is transforming drug discovery and development through Deep Quantum Modeling and AI. Driven by the belief that current methods limit the medicines the world can create, he built Verseon to systematically design therapeutics previously out of reach and elevate the standard of care across major diseases. Before Verseon, he founded Pulsent Corporation, developing foundational technologies that power modern video streaming. His work across physics, computation, and engineering has produced more than 40 patent families, and he holds a BS in Physics and Mathematics from Caltech.Takeaways:Verseon aims to redefine drug discovery through AI and quantum modeling.The journey of drug discovery has been long and challenging.Current drug development models are outdated and inefficient.AI's role in drug discovery is often limited to existing data.Deep quantum modeling offers a new approach to drug design.The pharmaceutical industry faces dismal odds in drug development.Innovative
